http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006002348-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6793134fe291272e4c4614972e3ae04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e3f538daefb645d98fec27f1b5a0e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_617324776afb968c9f0fe098496c8075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2b03ac6bdddb598220d7119a31b4603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fb5b6e3dca1bbfaa7d746487fe91ac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71979d67a090d93ac0e40d365c9b6097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aec4da2ebbc813db4e8104e10da2710
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
filingDate 2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71842c20847ef24c1a028fa3a0e394fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6df96f5e54c83332d4eb2aa8bceb6bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d9c9c2bc1be0be5789408af1bf997d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68adf00d4e4e67b627d08e1c2daff80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d82d300c8d4b87a869995a4900a21ad4
publicationDate 2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006002348-A3
titleOfInvention Solid and crystalline ibandronic acid
abstract Provided are novel crystalline and amorphous forms of ibandronic acid, methods for their preparation, and pharmaceutical compositions containing them. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form (or amorphous).
priorityDate 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03097655-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005044831-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005063779-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4927814-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60852

Total number of triples: 33.